Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Growth hormone illegal for off-label anti-aging use

26.10.2005


Because of 1988 and 1990 amendments to the Food, Drug and Cosmetic Act, off-label distribution or provision of human growth hormone to treat aging or age-associated illnesses is illegal in the United States, according to a report in the Journal of the American Medical Association.

The findings, which were peer-reviewed by independent experts and by the journal’s legal counsel, appear in the Oct. 26 issue.

A team of three noted health researchers revealed a largely unknown and unenforced law that thousands of entrepreneurs and physicians are breaking. The authors are Dr. Thomas Perls, director of the New England Centenarian Study at Boston Medical Center and associate professor of medicine at Boston University School of Medicine; Dr. Neal Reisman, clinical professor of plastic surgery at Baylor College of Medicine and associate chief of plastic surgery at St. Luke’s Episcopal Hospital, who is also an attorney; and S. Jay Olshansky, professor of epidemiology at the University of Illinois at Chicago School of Public Health.



Human growth hormone, or HGH, is a substance released by the pituitary gland that spurs growth and development in children and adolescents. As a drug, it can be prescribed legally only for three rare conditions: HGH deficiency-related syndromes that cause short stature in children, adult HGH deficiency due to rare pituitary tumors and their treatment, and muscle-wasting disease associated with HIV/AIDS. According to the U.S. Food and Drug Administration, any and all other uses of the drug, including the off-label use as an alleged treatment for aging and its related conditions, are illegal.

But many Web sites and anti-aging clinics market HGH with claims that the hormone stops and reverses aging and provides many other benefits, including improved nail and hair growth, better sleep, improved skin tone, better digestion, increased strength, weight loss, better eyesight and enhanced sexual function.

"Prescribing and administering HGH has become a routine intervention in an industry that is variably called anti-aging, regenerative, longevity or age management medicine," said Perls. "Hundreds of thousands of patients who have received HGH in recent years as a purported treatment for aging are unaware that they are receiving the drug illegally.

"Although there is no evidence that HGH administration stops or reverses aging, many people spend a great deal of money on these products," Perls said. "On the contrary, responsibly conducted and peer-reviewed science indicates that HGH could in fact accelerate aging and shorten lifespan. It is associated with very high rates of serious adverse effects, and long-term use could increase one’s risk of cancer."

According to Olshansky, "off-label use for many drugs is a normal and accepted practice in medicine, but that is not true for growth hormone. According to laws instituted by Congress more than 10 years ago, HGH can only be distributed for indications specifically authorized by the Secretary of Health and Human Services, and aging and its related disorders are not among them. The use of HGH as an alleged anti-aging intervention is a major public health concern not just because it is illegal, but also because its provision for anti-aging is not supported by science and it is potentially harmful."

Despite the fact that the vast majority of HGH prescriptions should be for children, 74 percent of HGH prescriptions in 2004 were for people 20 and older, and 44 percent were for people 40 to 59. Sales of HGH in 2004 totaled $622 million (almost 213,000 prescriptions) not including sales via anti-aging Web sites. "These data suggest that a very large proportion of HGH sales are for illegal uses," said Perls.

HGH is also distributed through the Internet, often at a high cost and in some cases without physician supervision, according to the researchers. Various forms of HGH -- ranging from pills to sprays to injectables -- are sold to consumers at a cost of $200 to $1,000 per month. One Web site alone was estimated by the Federal Trade Commission to have generated more than $70 million in sales of pills and sprays purported to contain HGH or to stimulate its production.

"Millions of dollars in profits are made off of useless pills and sprays like these," Perls said. "Pills with HGH are destroyed in the stomach, and because the molecule is too large to enter the blood stream via sublingual and nasal sprays, such products have absolutely no biological effect. You might as well be paying hundreds of dollars for sand and water."

"In 1988 and again in 1990, the [Food, Drug and Cosmetic Act] enacted very stringent controls with substantial penalties involving the distribution of HGH," said Reisman.

Despite the fact that HGH is not a Schedule III drug, like, for example, anabolic steroids, Congress specifically authorized the Drug Enforcement Agency to investigate offenses related to HGH distribution.

"Hopefully our paper will raise awareness of the legal issues surrounding the improper distribution, marketing, and provision of HGH and discourage this criminal practice," Reisman said.

Sherri McGinnis Gonzalez | EurekAlert!
Further information:
http://www.uic.edu
http://www.bumc.bu.edu/centenarian
http://www.bcm.edu

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>